OR

Origami Therapeutics, Inc.

YC W22

San Diego, US · Founded 2015 · 4 employees · 1 known investors

origamitherapeutics.com ↗

Origami Therapeutics is a preclinical-stage biopharmaceutical company developing protein degrader therapeutics to treat neurodegenerative diseases, starting with Huntington's disease. The company uses a proprietary platform that harnesses the body's natural protein disposal system to degrade disease-causing proteins.

Founders & leadership· Y Combinator alumni (W22)

Beth Hoffmanin𝕏Founder, President and CEO

LS

Leslie SchulzeCo-Founder and CFO

Investors · 1

Y

Y CombinatorMountain View · $500K – $500K